CL vs REPL
Colgate-Palmolive Company (CL) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
REPL does not have a complete income-statement cache yet.
CL currently screens at market cap $70.88B and trailing P/E 34.3. REPL currently screens at market cap $825.7M.
Not investment advice. Open the CL and REPL stock pages for the full models.
Not investment advice.